Article Text

other Versions

Download PDFPDF
Septal ablation for hypertrophic cardiomyopathy: outcomes in the past, the present and the future
  1. Robbert Steggerda1,
  2. Jurriën ten Berg2
  1. 1Department of Cardiology, Martini Hospital, Groningen, The Netherlands
  2. 2Department of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands
  1. Correspondence to Dr Robbert Steggerda, Department of Cardiology, Martini Hospital, Van Swietenplein 1, Groningen, Groningen 9728NT, The Netherlands; r.c.steggerda{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The first descriptions of alcohol septal ablation (ASA) arose around 1994–1995. Based on the findings of a gradient reduction during temporary balloon occlusion of the first septal branch, combined with the long-lasting experience of transcoronary injection of ethanol for cardiac arrhythmia, this method was further developed.

During the first procedures, an inflated balloon was temporarily placed in the first septal branch to induce ischaemia. Simultaneous pressure recordings with a catheter in the left ventricle and the aorta were used to observe a reduction of at least 30% of the gradient. When a pressure drop was observed, 96% of ethanol (average 4–6 mL) was injected through the balloon catheter in order to induce a sustained reduction of the gradient.

The first reported periprocedural mortality rate in 62 patients was 4%, and permanent pacemaker (PM) implantation was necessary in 38% of all patients. The potential risk of ventricular rhythm disturbances was recognised from the inception of the ASA procedure. An extensive study was published in 1999 by Gietzen et al, including electrophysiological testing and a pathoanatomical study. Surprisingly, electrophysiological induction of sustained ventricular tachycardia (VT) occurred only in 2.6% of patients after the ASA procedure. This was much lower than the 20%–34% reported inducible sustained VT after myocardial infarction. The histological pattern of the alcohol-induced scar showed a different pattern as compared with the one known after myocardial infarction. ‘A well-defined area, characterized by a homogeneous necrosis with contracted fibers encircled by a sharply demarcated scar’ was thus seen in deceased ASA patients.1 This was thought to be the reason why patients after ASA …

View Full Text


  • Contributors The article was written by RS in collaboration with JtB.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles